Minji Byun Assistant Professor, Microbiology & Molecular Genetics University of California, Irvine
Our research focuses on how DNMT3A and TET2 mutations disrupt DNA methylation, reshape immune cell function, and drive age-related diseases. We use advanced genetic, epigenetic, and stem cell–based models to uncover mechanisms behind clonal hematopoiesis and pathology.
Eddie Wook-Jin Chae Assistant Professor, Philips Institute for Oral Health Research Virginia Commonwealth University
Our research develops novel cancer immunotherapies for head and neck cancer by targeting immune mechanisms that regulate myeloid and Natural Killer cells. We also investigate platelet–macrophage interactions in oral mucosal inflammation. Together, these studies aim to uncover new therapeutic strategies to boost anti-tumor immunity and control inflammation.
Cheong-Hee Chang Professor of Microbiology and Immunology and the Immunology Program University of Michigan Medical School
My laboratory focuses on investigating on the molecular and cellular mechanisms that govern immune function by T cells. Our recent studies revealed that iron homeostasis is crucial for naïve T cell maintenance by controlling mitochondrial integrity and metabolic programming. We are currently working to understand the underlying mechanisms.
Michael Cho Professor, Biomedical Sciences Iowa State University
Development of a vaccine against human immunodeficiency virus (HIV-1), the virus that causes AIDS. In connection with this research, we characterize biochemical and immunological properties of viral envelope glycoprotein, develop and evaluate novel vaccine vectors, and examine virus-host interactions at various levels.
Chloe (Youn Jung) Choi Assistant Professor, Department of Medicine Cedar Sinai Medical Center
My lab focuses on the innate immune response in respiratory diseases, with a particular interest in mast cells and macrophages. We’re exploring their roles in the progression of inflammatory lung diseases, including asthma and lung fibrosis. By leveraging mechanistic insights, we aim to identify novel therapeutic strategies targeting innate immune molecules.
Jaehyuk Choi Inaugural Director of the new Center for Cellular Therapies and Cancer Immunology, Vice Chair for Translational Research and Innovation in the Department of Dermatology University of Texas Southwestern
The goal of the Choi Lab is to develop novel immunotherapies. To accomplish this, we first utilize high-dimensional approaches on human disease samples. This approach identifies targetable disease-promoting molecular defects in immune cells. Then, we utiize engineering approaches to reverse molecular changes.
Kyunghee Choi Professor, Pathology & Immunology Washington University in St. Louis, School of Medicine
Our lab investigates hematopoietic and endothelial development, focusing on how VEGF, Flk1, and ETV2 regulate lineage commitment. We also study hematopoiesis and angiogenesis in cancer, examining how tumors alter stem and progenitor cells and how angiogenesis shapes immunity, with the goal of developing strategies to modulate tumor growth.
Younho Choi Assistant Professor Cleveland Clinic Florida Research and Innovation Center
Our research explores viral immune evasion, genetics, pathogenesis, host recognition, and vaccine development. We focus on emerging tick-borne viruses such as SFTSV and HRTV, aiming to define mechanisms of immunopathogenesis and advance strategies for prevention and treatment
Yongwon Choi Leonard Jarett Professor of Pathology and Laboratory Medicine Perelman School of Medicine, University of Pennsylvania
Dr. Choi studies the osteoimmune system, focusing on how bone metabolism and the immune system regulate each other. His research investigates dendritic cell and osteoclast differentiation and T cell tolerance in vivo. By uncovering these mechanisms, his work aims to improve treatments for inflammatory bone diseases, osteoporosis, and tumor-induced bone loss.
Hachung Chung Assistant Professor, Department of Microbiology and Immunology Columbia University, New York
New discoveries of RNA function have expanded the role of RNA beyond just a messenger for protein synthesis. The highly dynamic nature of RNA structure is key to diversifying RNA function. Notably, certain RNA structures can act as immunostimulatory molecules. Our laboratory investigates how and when RNA structures elicit an immune response as it has profound implications for human health, especially for autoimmune and neurodegenerative diseases.
Yousang Gwack Associate Professor, Physiology University of California, Los Angeles
Our lab investigates Ca²⁺ signaling in immune cells, focusing on Orai1, the pore-forming subunit of CRAC channels. We study how the Orai1–NFAT pathway regulates immunity and explore strategies to modulate its activity, aiming to develop therapies for autoimmunity, inflammatory diseases, and immune deficiencies.
Bumsuk Hahm Professor, Molecular Microbiology and Immunology University of Missouri, Columbia Our research is focused on investigating the mechanisms of RNA virus-host interaction, viral regulation of host immunity, and viral pathogenesis. We create and utilize small-animal models and tissue culture systems for infection with RNA viruses such as influenza virus and lymphocytic choriomeningitis virus (LCMV). Our study should assist in the development of novel therapies including anti-viral drugs and immune therapeutics to remedy diseases caused by viral infections.
Young S Hahn Professor, Microbiology, Immunology, and Cancer Biology University of Virginia We investigate how Hepatitis C virus (HCV) evades immunity and drives chronic liver disease. Our research focuses on exosomes from HCV-infected hepatocytes, which display TGF-β and suppress T cell responses. By uncovering these mechanisms, we aim to develop immunotherapies to prevent viral persistence, fibrosis, cirrhosis, and liver cancer.
Cecil Han Assistant Professor Georgetown University Dr. Han's research programs focus on 1) The role of RNA-binding proteins and non-coding RNAs in cancer development and progression, 2) Ovarian and Lung cancer initiation and progression, 3) Developing novel therapeutic strategies for cancer based on cancer genomics and metabolomics.
Jun Huh Associate Professor of Immunology Harvard Medical School
Our lab investigates the gut–immune–brain axis, uncovering how maternal gut bacteria trigger immune cascades that disrupt fetal brain development and social behaviors. We focus on Th17 cells and small molecules that mediate immune–neural communication, aiming to reveal mechanisms of inflammation-driven behavioral changes and potential therapeutic targets.
Sun Hur Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Our lab studies the molecular mechanisms of vertebrate immunity, with a focus on “functional aggregates”—protein assemblies that regulate immune responses. We discovered that RIG-I-like receptors form filaments during viral RNA detection, and now explore how controlled protein aggregation shapes antiviral signaling and transcriptional regulation in adaptive immunity.
Seungmin (Sam) Hwang Senior Translation Group Leader, Center for Integrated Solutions for Infectious Diseases Broad Institute of MIT and Harvard
The main research theme of Hwang Lab is to understand host-pathogen interactions for the goal of developing host-directed therapy (HDT) for infectious diseases. Hwang lab is particularly interested in how the host controls or tolerates acute and chronic infections using functional genomics approaches.
Jin Seon Im Assistant Professor, Dept. of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Our research focuses on the CD1 antigen-presenting system and CD1-restricted T cells in immune regulation. We study invariant Natural Killer T (iNKT) cells post–stem cell transplantation, developing iNKT-based therapies to prevent GVHD and enhance anti-leukemic effects using CAR engineering, integrating molecular, cellular, and in vivo approaches.
Jae Jung Betsy deWindt Professor, Chair of Cancer Biology Department,Director of Infection Biology Program and Director of Global Center for Pathogen Research and Human Health Lerner Research Institute, Cleveland Clinic
Our research spans virus-induced cancers, emerging viruses (including Dengue, Zika, SARS-CoV-2, and influenza), therapeutic and vaccine development, and host immunity. We aim to uncover mechanisms of infection and immune regulation, while rapidly advancing vaccines and treatments to address viral diseases and improve global health.
Insoo Kang Professor; Director of Allergy & Immunology, Internal Medicine Yale School of Medicine Dr. Insoo Kang, Professor of Medicine at Yale School of Medicine, is a physician-scientist specializing in human immunology. His research focuses on defining T cell subsets through cytokine receptor expression and investigating their interactions with monocytes and other immune cells in health and disease.
Joonsoo Kang Professor; Pathology UMass Chan Medical School Our lab studies T lymphocyte development and function to understand how failures in these processes lead to leukemia, lymphoma, and autoimmunity. We also investigate ways to enhance T cell activity for cancer immunotherapy, aiming to design precise treatments that maintain self-tolerance while boosting anti-tumor immunity.
Sang-Moo Kang Professor, Institute for Biomedical Sciences Georgia State University Research Interest: Design of vaccines based on mRNA genetic and recombinant protein platforms. Developing effective vaccines against respiratory viruses: Influenza Virus, SARS-CoV-2 (COVID-19), Human Respiratory Syncytial Virus (RSV). Understanding protective immune responses of vaccination.
Byung S Kim Professor Emeritus of Microbiology-Immunology Northwestern University
Chang H. Kim Kenneth and Judy Betz Family Endowed Professor of Pathology, Food Allergy Research, and Immunology University of Michigan
The Kim Lab investigates how metabolites and signaling pathways shape immune regulation at mucosal sites. Recent work has defined roles of retinoic acid and microbial short-chain fatty acids in inducing Tregs, effector T cells, and plasma B cells, and uncovered gut-homing mechanisms of innate lymphoid cell subsets.
Dong-Hyun Kim Associate Professor of Radiology Northwestern University
Our research develops multifunctional micro- and nanoparticles as therapeutic carriers for cancer. These platforms are designed for drug delivery, hyperthermia, cell therapy, immunotherapy, and molecular imaging (MRI, CT, ultrasound, fluorescence). Working closely with clinicians and scientists, we aim to translate these nanotechnology-based therapies and diagnostics into clinical applications.
Brian S. Kim Professor Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research The Kim Lab has unique expertise in basic approaches and techniques in innate immunity, neuroimmunology, and behavioral modelling of chronic itch. Therefore, we are able to provide state of the art guidance on in vitro, ex vivo, and in vivo experimental systems to better understand skin immunity, inflammation, and sensation.
Kiwook Kim Associate Professor, Department of Pharmacology and Regenerative Medicine University of Illinois at Chicago Our lab studies the development and functions of mononuclear phagocytes in health and disease using lineage tracing, in vivo imaging, and transcriptomics. We focus on monocyte subsets in inflammation and resolution, their transition into macrophages or dendritic cells, and distinct roles of embryonic- versus monocyte-derived macrophages in tissue repair and pathology.
Minsoo Kim Professor of Department of Microbiology and Immunology University of Rochester Medical Center Dr. Kim studies integrin regulation of cell adhesion and migration in immunity, development, wound healing, and cancer. He pioneered live-cell FRET imaging to reveal integrin conformational changes during immune cell migration, a landmark discovery, and continues to define roles of key integrins such as LFA-1, Mac-1, and VLA-4.
Sangwon V. Kim Assistant Professor of Department of Microbiology and Immunology Thomas Jefferson University Our lab investigates how T cells maintain immune homeostasis in non-lymphoid tissues, focusing on the intestine as a model. We study how T cells migrate to the gut, the antigens they recognize, and how local environments such as the microbiota shape their roles in mucosal immunity.
Sun Jung Kim Associate Professor, Institute of Molecular Medicine Feinstein Institutes for Medical Research
Dr. Kim’s lab investigates how dendritic cells regulate inflammation under homeostatic and disease conditions. Using animal models, including dendritic cell–specific Blimp-1 deletion in lupus, the lab seeks to uncover molecular mechanisms that suppress autoimmunity, with a focus on systemic lupus erythematosus and inflammatory bowel disease.
Sungjin Kim Associate Professor, Medical Microbiology and Immunology University of California, Davis Innate immune responses to viral infection and malignancy, Development and function of natural killer cells in humans and animal models, Non-human primate model of viral infection.
Tae Kon Kim Assistant Professor, Department of Medicine/Pathology, Molecular Microbiology and Immunology VANDERBILT University 1. Overcoming immune evasion in leukemia 2. Dissect graft-versus-host disease and graft-versus-leukemia in allogeneic stem cell transplantation (allo-SCT) by manipulating co-inhibitory molecules 3. Human correlative studies in line with clinical trials
Andrew Koh Assistant Professor, Pathology, Institute for Biophysical Dynamics, Center for Chemical Biology and Therapeutics University of Chicago Understanding the design principles in the immune system that allow somatic cells to alter their fate, and how the underlying mechanisms are exploited in autoimmunity and cancer. Special focus on the role of chromatin and epigenetic noise in specifying the range of cellular fates that can be sampled by differentiated cells
Jean Kwun Associate Professor, Department of Surgery and Pathology Duke University My lab focuses on promoting tolerance in organ transplantation. I am particularly interested in preventing antibody-mediated rejection (AMR) in both allo- and xenotransplantation and in establishing a conceptual framework that can be translated into clinical therapies for AMR
Chun Lee PROFESSOR, DEPARTMENT OF MOLECULAR MICROBIOLOGY AND IMMUNOLOGY Brown University
My role in basic and clinical research has largely derived from my position as Director of the Molecular Biology Core in the Section of Pulmonary Medicine. In that capacity, I have generated and characterized lung-specific overexpressing transgenic and null mutant mice to study in vivo roles and the effect of various cytokines in the pathogenesis of asthma, acute lung injury, pulmonary vascular disease, pulmonary fibrosis and emphysema.
Eun Lee Assistant Professor, Microbiology and Immunology Virginia Commonwealth University Reproductive immunology, T cells, NK cells, ERAP2, Cancer Immunology, Cancer Therapy, angiogenesis, peptide presentation, allogeneic rejection, transplant immunology, polyoma virus, Sneathia, polyoma virus
As a pulmonary immunologist, her research focus is in understanding the biology of human plasma cells in health and disease in bone marrow, blood, and respiratory tissues. Recently, her laboratory has identified a unique phenotype of human long-lived plasma cells (LLPC) in the bone marrow, and she is interested in understanding the mechanisms of how protective and pathogenic plasma cells are generated and maintained.
Francis Lee Wayne O. Southwick Professor of Orthopaedics and Rehabilitation Yale School of Medicine
Bone and Bones; Bone Diseases, Infectious; Bone Marrow; Fracture Fixation; Musculoskeletal Diseases; Orthopedics; Osteoarthritis; Osteoblasts; Osteoclasts; Stem Cells; Oncology Service, Hospital; Tissue Engineering
Jongbok Lee Assistant Professor, Department of Biochemistry & Molecular Biology University of Calgary The ability of immune cells to target cancer cells has revolutionized cancer treatments. Adoptive cellular therapy directly utilizes immune cells to treat cancers as living drugs and offers promising treatment strategies for some patients with no alternative options. Dr. Jongbok Lee’s research focuses on developing novel ACT using a subset of immune cells called double-negative T cells (DNT).
Jongsoon Lee Professor, President of Soonchunhyang Institute of Medi-bio Science (SIMS) Soonchunhyang University The Lee Lab investigates how obesity alters immune cell function to drive systemic insulin resistance. Current projects focus on adipose tissue macrophages, the role of NK cells in obesity-induced inflammation, and the molecular mechanisms linking adipose tissue inflammation to insulin resistance in the liver, muscle, and pancreatic β-cells.
Sanghyun Lee Assistant Professor, Molecular Microbiology and Immunology Brown University Research interest: Host-Virus interaction in cells and animals. Immune responses controlling viral infection and viral counteractions.
Seung-Hwan Lee Professor, Dept. of Biochemistry, Microbiology, and Immunology The University of Ottawa
Our lab studies natural killer (NK) cells, focusing on discovering novel NK cell functions and the mechanisms that underlie them in infection and cancer. We translate these insights into innovative therapeutics through collaborations with clinical investigators, aiming to advance cancer treatment and therapies for chronic infections.
Sujin Lee Assistant Professor, Department of Pediatrics Emory University School of Medicine
Dr. Sujin Lee’s research focuses on T cell immunity and vaccine development against respiratory syncytial virus (RSV). Her lab develops peptide-based vaccines with TLR agonists and studies immune responses in both healthy and aged hosts, aiming to generate durable protective memory and establish novel strategies for effective RSV vaccination.
Jean K. Lim Associate Professor, Department of Microbiology Icahn School of Medicine at Mount Sinai Dr. Lim, Associate Professor of Microbiology at the Icahn School of Medicine, studies host responses to viral infections with a focus on how inflammation shapes viral pathogenesis. Trained at the NIH and University of Maryland, her research aims to uncover mechanisms driving infection outcomes and identify targets for intervention.
Booki Min Professor of Microbiology-Immunology Northwestern University
Our lab investigates the biology of Foxp3⁺ regulatory T (Treg) cells, key regulators of immune tolerance. We study cellular and molecular mechanisms that govern Treg development and function, and how their dysregulation contributes to autoimmunity and chronic inflammation, aiming to uncover new strategies for restoring immune balance.
James Moon J. G. Searle Professor, Pharmaceutical Sciences University of Michigan, Ann Arbor
Our group develops novel therapeutics at the intersection of immunology, engineering, and pharmaceutical sciences. We design nanotechnology-based drug delivery systems targeting lymphoid organs and the gut microbiome to advance vaccines and immunotherapies for cancer, infection, and autoimmunity. Our work has led to high-impact publications, patents, and biotech startups.
Jim Moon Assistant Professor, Center for Immunology and Inflammatory Disease Massachusetts General Hospital, Harvard Medical School
Our lab investigates how overlapping mechanisms of tolerance regulate T cell responses to self and commensal microbial antigens. Using peptide:MHC tetramers in conjunction with genetic models to directly identify populations of T cells with specificity to these antigens, we study how their activation during inflammatory events leads to epitope spreading with tolerogenic or autoimmune outcomes.
Moon Nahm Professor - Emeritus (P), Department of Medicine The University of Alabama at Birmingham
Dr. Moon H. Nahm, Professor of Medicine with a secondary appointment in Microbiology at UAB, earned his BA and MD from Washington University in St. Louis. After residency and postdoctoral training there, he served on the faculties of Washington University and the University of Rochester, and directed UAB’s Clinical Immunology Laboratory.
Jaehak Oh CEO & Founder, QUM Therapeutics Accomplished and innovative scientific leader with a Ph.D. in Immunology and a proven track record of managing novel immune-oncology pipeline projects. Deep understanding and expertise in cancer immunology and immunology, demonstrated through first-author publications, invited oral presentations, and patent applications. Skilled in project management, team leadership, and critical thinking, driving scientific excellence and innovation.
Gye Young Park Professor of Medicine University of Illinois, College of Medicine
Our lab investigates the molecular and cellular mechanisms of immune cells with a translational focus on human lung disease. Using tools such as flow cytometry, scRNA-seq, and CyTOF, we study macrophage and dendritic cell heterogeneity in asthma, integrating human samples, animal models, and bronchoscopic provocation studies to advance pulmonary immunology.
Jin Mo Park Associate Profesor Massachusetts General Hospital
Joon Seok Park Assistant Profesor, Biological Science Division University of Chicago
Microbiome and Cancer Immunology, Microbiome-derived molecules, Immune receptor signaling, T-cell mediated immunity
Jung-Hyun Park Senior Investigator, Experimental Immunology Branch NIH/NCI Our lab studies how cytokines regulate immune cell homeostasis in both steady state and disease. We investigate how naive and memory T cells occupy distinct cytokine niches and how inflammatory signals, such as IL-2, IL-4, and IL-6, alter IL-7 receptor expression to reshape T cell survival and function.
Juwon Park Associate Professor, Tropical Medicine, Medical Microbiology and Pharmacology University of Hawaii at Manoa My lab studies how innate immune cells interact with fibroblasts and epithelial cells to regulate tissue homeostasis and inflammation. We focus on neutrophil and monocyte/macrophage dysfunction in infectious diseases, aiming to identify therapeutic targets that reduce severity, prevent chronic inflammation, and limit long-term tissue injury.
Hyewon Phee Scientific Director, Gastroenterology Drug Discovery Research Takeda Pharmaceuticals
• Immunologist in Drug Discovery Research in the field of Cancer Immunotherapy and Inflammatory autoimmune diseases • Project leader for multiple Target Discovery Programs in Immuno-oncology and Inflammatory autoimmune diseases • Leading Translational Research with academic collaborators to determine endotypes of COPD and discover biomarkers for respiratory inflammation through immunophenotyping, nasal RNA-Seq, and single-cell RNA-seq
Dohun Pyeon Professor, Department of Microbiology, Genetics, and Immunology Michigan State University
Our research program aims to uncover the underlying mechanisms of how human papillomavirus (HPV) dysregulates host immune responses, driving cancer progression and immune escape, and to develop effective immunotherapeutic strategies against HPV-driven cancers.
Jae-Hyuck Shim Associate Professor, Department of Medicine UMass Chan Medical School
Our lab studies the balance between osteoblasts and osteoclasts in bone remodeling, a process central to skeletal health. We investigate how dysregulation leads to disorders such as osteoporosis, inflammation-induced bone loss, and periodontitis, and how skeletal stem cell differentiation controls bone formation, fragility, healing, and pathological ossification.
Haina Shin Senior Program Officer Bill and Melinda Gates Foundation
Research interest: reproductive health and vaccines against sexually transmitted infections
Jeoung-Sook Shin Assoc. Professor, Department of Microbiology and Immunology University of California, San Francisco Our lab investigates how dendritic cells regulate immune tolerance through Treg development. We focus on the role of MARCH1 ubiquitin ligase in dendritic cell–mediated selection of natural Tregs and aim to define the molecular mechanisms and functional specialization of Tregs generated through this pathway.
Woong-Kyung Suh Director, Immune Regulation Research Unit IRCM Research Professor
The Immune Regulation Research Unit studies how CD28–B7 family cosignaling pathways control T cell immunity and tolerance. Using knockout, knockin, and transgenic mouse models, we investigate the molecular and cellular mechanisms of T cell regulation and examine their impact on infection, cancer, autoimmunity, and overall immune responses.
The Sung lab applies quantitative imaging, mathematical, epigenomics approaches towards understanding the mechanisms of transcription factor signaling and functional genome regulation. They developed fluorescent knock-in mice that track the canonical subunits of NF-κB (Rahman SMT et al. Cell Reports, 2022) to enable diverse analyses, ranging from single-molecule analyses to in situ identification of active inflammatory cells.
Ae-Kyung Yi Professor, Dept. of Microbiology, Immunology and Biochemistry The University of Tennessee Health Science Center
Research Interests: Research focuses on identifying new signaling components in host pattern recognition reeceptor and signaling pathways that amplify or attenuate pro-inflammatory responses during the course of infection and autoimmune process.